Astrazeneca (AZN) Prepaid Assets (2015 - 2025)

Astrazeneca's Prepaid Assets history runs 11 years deep, the most recent figure standing at $2.0 billion for Q4 2025.

• In Q4 2025, Prepaid Assets rose 17.1% year-over-year to $2.0 billion; the TTM figure through Dec 2025 stood at $2.0 billion (up 17.1% YoY), while the FY2025 annual figure was $2.0 billion, up 17.1% from the prior year.
• Prepaid Assets was $2.0 billion for Q4 2025 at Astrazeneca, up from $1.7 billion in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $2.0 billion in Q4 2025 to a low of $706.0 million in Q1 2021.
• Historically, Prepaid Assets has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2021.
• The sharpest annual moves came in 2021 and 2023: Prepaid Assets declined 12.85% in 2021, then gained 21.67% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $1.5 billion in 2021, then slipped by 12.1% to $1.3 billion in 2022, then climbed by 21.67% to $1.6 billion in 2023, then climbed by 7.42% to $1.7 billion in 2024, then increased by 17.1% to $2.0 billion in 2025.
• The last three Prepaid Assets figures came in at $2.0 billion (Q4 2025), $1.7 billion (Q4 2024), and $1.6 billion (Q4 2023), per Business Quant data.